139 related articles for article (PubMed ID: 19968328)
1. Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population.
Shariff MI; Ladep NG; Cox IJ; Williams HR; Okeke E; Malu A; Thillainayagam AV; Crossey MM; Khan SA; Thomas HC; Taylor-Robinson SD
J Proteome Res; 2010 Feb; 9(2):1096-103. PubMed ID: 19968328
[TBL] [Abstract][Full Text] [Related]
2. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study.
Cox IJ; Aliev AE; Crossey MM; Dawood M; Al-Mahtab M; Akbar SM; Rahman S; Riva A; Williams R; Taylor-Robinson SD
World J Gastroenterol; 2016 Apr; 22(16):4191-200. PubMed ID: 27122669
[TBL] [Abstract][Full Text] [Related]
3. The Plasma and Serum Metabotyping of Hepatocellular Carcinoma in a Nigerian and Egyptian Cohort using Proton Nuclear Magnetic Resonance Spectroscopy.
Shariff MIF; Kim JU; Ladep NG; Gomaa AI; Crossey MME; Okeke E; Banwat E; Waked I; Cox IJ; Williams R; Holmes E; Taylor-Robinson SD
J Clin Exp Hepatol; 2017 Jun; 7(2):83-92. PubMed ID: 28663670
[TBL] [Abstract][Full Text] [Related]
4. Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans.
Ladep NG; Dona AC; Lewis MR; Crossey MM; Lemoine M; Okeke E; Shimakawa Y; Duguru M; Njai HF; Fye HK; Taal M; Chetwood J; Kasstan B; Khan SA; Garside DA; Wijeyesekera A; Thillainayagam AV; Banwat E; Thursz MR; Nicholson JK; Njie R; Holmes E; Taylor-Robinson SD
Hepatology; 2014 Oct; 60(4):1291-301. PubMed ID: 24923488
[TBL] [Abstract][Full Text] [Related]
5. Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.
Shariff MI; Gomaa AI; Cox IJ; Patel M; Williams HR; Crossey MM; Thillainayagam AV; Thomas HC; Waked I; Khan SA; Taylor-Robinson SD
J Proteome Res; 2011 Apr; 10(4):1828-36. PubMed ID: 21275434
[TBL] [Abstract][Full Text] [Related]
6. Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.
Zhan Z; Guan Y; Mew K; Zeng W; Peng M; Hu P; Yang Y; Lu Y; Ren H
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G305-G312. PubMed ID: 31736338
[TBL] [Abstract][Full Text] [Related]
7. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
[TBL] [Abstract][Full Text] [Related]
8. Study of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosis.
Dai W; Yin P; Chen P; Kong H; Luo P; Xu Z; Lu X; Xu G
Anal Bioanal Chem; 2014 Jul; 406(18):4325-35. PubMed ID: 24817358
[TBL] [Abstract][Full Text] [Related]
9. Urinary Metabotyping of Hepatocellular Carcinoma in a UK Cohort Using Proton Nuclear Magnetic Resonance Spectroscopy.
Shariff MI; Kim JU; Ladep NG; Crossey MM; Koomson LK; Zabron A; Reeves H; Cramp M; Ryder S; Greer S; Cox IJ; Williams R; Holmes E; Nash K; Taylor-Robinson SD
J Clin Exp Hepatol; 2016 Sep; 6(3):186-194. PubMed ID: 27746614
[TBL] [Abstract][Full Text] [Related]
10. Chromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patients.
Osman D; Ali O; Obada M; El-Mezayen H; El-Said H
Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 27862090
[TBL] [Abstract][Full Text] [Related]
11. Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients.
Abdelsameea E; Nada A; Omar N; Saleh SM; Naguib M; El-Ezawy HEM; Bakry L; Elsabaawy M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2259-2264. PubMed ID: 32856853
[TBL] [Abstract][Full Text] [Related]
12. Urinary biomarkers of catechins and risk of hepatocellular carcinoma in the Shanghai Cohort Study.
Butler LM; Huang JY; Wang R; Lee MJ; Yang CS; Gao YT; Yuan JM
Am J Epidemiol; 2015 Mar; 181(6):397-405. PubMed ID: 25713334
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma presentation and prognosis among Nigerian adults with and without HIV.
Davwar PM; Okeke E; Duguru M; Nyam D; Bell K; Odeghe EA; Oyeleke G; Lesi OA; Singh R; Kim KY; Imade G; Akanmu AS; Sagay AS; Ogunsola FT; Peters MG; Roberts LR; Hou L; Murphy RL; Hawkins CA
PLoS One; 2023; 18(3):e0282539. PubMed ID: 36877687
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.
Tsai JF; Jeng JE; Chuang LY; Yang ML; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Br J Cancer; 1997; 75(10):1460-6. PubMed ID: 9166938
[TBL] [Abstract][Full Text] [Related]
15. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
16. Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.
Tsai JF; Jeng JE; Chuang LY; Yang ML; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Br J Cancer; 1997; 76(2):244-50. PubMed ID: 9231926
[TBL] [Abstract][Full Text] [Related]
17. Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma.
Yuan JM; Grouls M; Carmella SG; Wang R; Heskin A; Jiang Y; Tan YT; Adams-Haduch J; Gao YT; Hecht SS
Carcinogenesis; 2019 Aug; 40(8):989-997. PubMed ID: 30615102
[TBL] [Abstract][Full Text] [Related]
18. Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Yang HI; Tseng TC; Liu J; Lee MH; Liu CJ; Su TH; Batrla-Utermann R; Chan HL; Kao JH; Chen CJ
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):461-468.e2. PubMed ID: 26598229
[TBL] [Abstract][Full Text] [Related]
19. Forms of diagnostic material as sources of miRNA biomarkers in hepatocellular carcinoma: a preliminary study.
Świtlik WZ; Bielecka-Kowalska A; Karbownik MS; Kordek R; Jabłkowski M; Szemraj J
Biomark Med; 2019 May; 13(7):523-534. PubMed ID: 30854869
[No Abstract] [Full Text] [Related]
20. Urinary 6 beta-hydroxycortisol excretion in Hong Kong Chinese patients with hepatocellular carcinoma and other chronic liver diseases.
Ng MC; Young RP; Critchley JA; Leung NW; Lau JW; Li AK
Cancer; 1996 Apr; 77(8):1427-33. PubMed ID: 8608525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
